Skip to main content
OpenTrials

Clinical trial condition

Thrombocytosis

Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.

177 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytosis trial results

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

NCT01259817

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Emory Hospital Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia

NCT01230775

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Uniklinik Innsbruck Innsbruck, Austria
  • Universitätsklinik für Innere Medizin III, Universitätsklinikum Salzburg Salzburg, Austria
  • Hanusch Krankenhaus Vienna, Austria
  • Sozialmedizinisches Zentrum Ost Vienna, Austria
View all 37 locations
View Trial Details
Completed

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

NCT01243073

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • MDACC - Orlando Orlando, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University - Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States
View Trial Details
Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

NCT00586651

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • NY Presbyterian-Cornell New York, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions